EP2914264
6-oxó-1,6-díhýdró-pýridasín afleiða til notkunar við að meðhöndla lifrarfrumukrabbamein (HCC)
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
4.10.2013EP published:
9.8.2017EP application number:
13776720.8
EP translation filed:
24.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
3.10.2033Expiry date:
3.10.2024
Title:
A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE FOR THE USE FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC)
Timeline
Today
4.10.2013EP application
9.8.2017EP Publication
24.8.2017Translation submitted
15.9.2017Registration published
3.10.2024Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293, Darmstadt, DE
Inventor
Name:
FRIESE-HAMIM, ManjaAddress:
Moerfelden-Walldorf, DE
Name:
BLADT, FriedhelmAddress:
Heidelberg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
12007494Date:
2.11.2012Country:
EP
Classification
Categories:
A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.9.2017
Expires: 3.10.2018
Payer: Árnason Faktor
Number: 6
Paid: 6.9.2018
Expires: 3.10.2019
Payer: Árnason Faktor
Number: 7
Paid: 9.9.2019
Expires: 3.10.2020
Payer: Árnason Faktor
Number: 8
Paid: 9.9.2020
Expires: 3.10.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2021
Expires: 3.10.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.9.2022
Expires: 3.10.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 25.9.2023
Expires: 3.10.2024
Payer: Árnason Faktor ehf.